Breaking News Headlines Today | Ground News

See every side of every news story

lifesciencesbc.ca image

News from lifesciencesbc.ca

Ground News rates lifesciencesbc.ca’s media bias as unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

lifesciencesbc.ca’s aggregated factuality score is Unknown. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about lifesciencesbc.ca

Where is lifesciencesbc.ca located?lifesciencesbc.ca's Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top lifesciencesbc.ca News

Neurocrine Biosciences to Present New Data From Phase 2 Study of Osavampator in Adults with Major Depressive Disorder at 38th Annual Psych Congress 2025

Vancouver, British Columbia · Vancouver

Neurocrine Biosciences to Present New Data From Phase 2 Study of Osavampator in Adults with Major Depressive Disorder at 38th Annual Psych Congress 2025

92% Center coverage: 13 sources

Additional Data from SAVITRI™ Study Expand on Top-Line Results Announced in April 2024SAVITRI Poster Presentation Chosen as Finalist for Psych Congress Poster Awards See the Story

AbbVie Submits New Drug Application to U.S. FDA for Tavapadon for the Treatment of Parkinson's Disease

Pharma · United States

AbbVie Submits New Drug Application to U.S. FDA for Tavapadon for the Treatment of Parkinson's Disease

100% Center coverage: 8 sources

/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for...See the Story

AI Scores Predict Cancer Aggressiveness: Hologic's Mammography Tech Shows Promise in Major Studies

Artificial Intelligence · Vancouver

AI Scores Predict Cancer Aggressiveness: Hologic's Mammography Tech Shows Promise in Major Studies

Studies show Hologic's Genius AI Detection 2.0 identifies aggressive breast cancers with 1-in-27 accuracy for highest risk cases. AI performance matches 108 radiologists in clinical trial.See the Story

Breaking News Topics Related to lifesciencesbc.ca